Post by Biogen on X
Biogen@biogen
X#News: Together with @StokeTx, we announced the first patient has been dosed in a Phase 3 study for our investigational therapy for Dravet syndrome. Read more: t.co
8 likes1 repliesPosted Aug 11, 2025
Loading the post